Molecular Targets for Tumor Radiosensitization
- 2 April 2009
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 109 (7) , 2974-2988
- https://doi.org/10.1021/cr800504x
Abstract
No abstract availableThis publication has 142 references indexed in Scilit:
- The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trialsEuropean Journal Of Cancer, 2008
- Targeting Hsp90: small-molecule inhibitors and their clinical developmentCurrent Opinion in Pharmacology, 2008
- HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsBrain Research, 2008
- Clinical biomarkers of angiogenesis inhibitionCancer and Metastasis Reviews, 2008
- Tumor–Microenvironment Interactions: Dangerous LiaisonsPublished by Elsevier ,2008
- Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma MultiformeInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applicationsJournal of Cellular Physiology, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- The ErbB receptors and their role in cancer progressionExperimental Cell Research, 2003
- The Hallmarks of CancerCell, 2000